相关实验视频

Updated: Jun 27, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

TRPV3通过EGFR/AKT通路调节乳腺癌细胞增殖和亡

Yan Xie¹, Hyo In Kim², Qianzhi Yang³

¹Basic Medicine College of Daqing Campus, Harbin Medical University-Daqing, Daqing, 163319, China.

Journal of Cancer

|May 6, 2024

概括

暂时受体潜在化物3 (TRPV3) 在乳腺癌中被上调. 抑制TRPV3抑制癌细胞迁移和扩散,同时通过EGFR/AKT通路促进细胞亡,这表明TRPV3是治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
细胞生物学细胞生物学

背景情况:

乳腺癌 (BC) 是全球癌症死亡的主要原因.
暂时受体潜在化物3 (TRPV3) 显示了与各种癌症的初步联系,包括BC.
了解TRPV3在BC中的作用对于开发新疗法至关重要.

研究的目的:

研究TRPV3在乳腺癌细胞中的功能作用.
阐明TRPV3在BC进展中的潜在分子机制.
评估向TRPV3在乳腺癌中的治疗潜力.

主要方法:

在BC组织和细胞系中使用RT-PCR和西欧斑块的量化TRPV3表达.
评估了细胞迁移 (伤口愈合),增殖 (MTT,EDU) 和细胞亡 (TUNEL,Caspase-3活性).
研究了表皮生长因子受体 (EGFR) 和AKT信号通路的参与.

主要成果:

在人类BC组织和细胞系中,TRPV3的表达显著升高.
抑制TRPV3抑制了BC细胞的迁移和增殖,并诱导了BC细胞的亡.
卡瓦克罗尔的TRPV3激活显示出相反的效果;向EGFR/AKT通路调节了这些变化.

结论:

TRPV3在促进乳腺癌细胞迁移和增殖方面发挥着重要作用.
通过siRNA抑制TRPV3,有效抑制了BC的进展.
EGFR/AKT通路是TRPV3在乳腺癌中的作用的关键调解者,突出显示TRPV3是潜在的治疗标.

关键词:

欧洲农业基金会 (EGFR) 是一个基金.在 TRPV3 中.灭症 (apoptosis) 是一种死亡的过程.乳腺癌乳腺癌乳腺癌它们的扩散和扩散.

更多相关视频

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Published on: May 1, 2015

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...